OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 66 filers reported holding OPHTHOTECH CORP in Q3 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $11,000 | -83.1% | 4,000 | -83.3% | 0.00% | – |
Q1 2018 | $65,000 | -30.9% | 23,885 | -20.9% | 0.00% | – |
Q4 2017 | $94,000 | -43.4% | 30,207 | -48.6% | 0.00% | – |
Q3 2017 | $166,000 | -6.7% | 58,776 | -14.9% | 0.00% | – |
Q2 2017 | $178,000 | +263.3% | 69,082 | +409.3% | 0.00% | – |
Q1 2017 | $49,000 | -98.8% | 13,563 | -98.5% | 0.00% | -100.0% |
Q4 2016 | $4,234,000 | -64.8% | 876,352 | +236.0% | 0.00% | -69.2% |
Q3 2016 | $12,032,000 | +533.9% | 260,831 | +601.3% | 0.01% | +333.3% |
Q2 2016 | $1,898,000 | +1246.1% | 37,195 | +1010.0% | 0.00% | – |
Q1 2016 | $141,000 | +166.0% | 3,351 | +397.9% | 0.00% | – |
Q4 2015 | $53,000 | -86.0% | 673 | -92.9% | 0.00% | – |
Q3 2015 | $378,000 | -91.2% | 9,452 | -88.5% | 0.00% | -100.0% |
Q2 2015 | $4,281,000 | -1.3% | 82,329 | -12.7% | 0.01% | 0.0% |
Q1 2015 | $4,339,000 | +0.3% | 94,309 | -4.1% | 0.01% | +25.0% |
Q4 2014 | $4,327,000 | -8.4% | 98,335 | -20.9% | 0.00% | -20.0% |
Q3 2014 | $4,726,000 | -14.9% | 124,394 | -5.9% | 0.01% | -16.7% |
Q2 2014 | $5,553,000 | +42615.4% | 132,222 | +36224.7% | 0.01% | – |
Q1 2014 | $13,000 | -99.4% | 364 | -99.5% | 0.00% | -100.0% |
Q4 2013 | $2,120,000 | – | 66,231 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,103,981 | $44,734,000 | 25.02% |
Novo Holdings A/S | 4,910,487 | $198,973,000 | 20.56% |
JHL Capital Group LLC | 3,265,000 | $132,298,000 | 14.62% |
AlpInvest Partners B.V. | 111,519 | $4,519,000 | 8.90% |
Opaleye Management Inc. | 105,000 | $4,255,000 | 2.09% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 16,110 | $653,000 | 2.05% |
IMA Wealth, Inc. | 66,061 | $2,623,000 | 1.66% |
WILLIAM HARRIS INVESTORS INC | 143,022 | $5,795,000 | 1.64% |
Orbimed Advisors | 1,923,500 | $77,940,000 | 0.79% |
Overbrook Management Corp | 117,807 | $4,774,000 | 0.74% |